Black Rose Industries Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Published 25 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹588 Cr

Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.

From Black Rose Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

📊 Revenue & Sales Performance

  • Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume.
  • Raw material prices have stabilized, aiding better price realization.
  • New products like acrylamide solid and N-methylol acrylamide (NMA) are steadily gaining market acceptance.
  • Capacity utilization for key products is improving, contributing to better margins and volume growth.
  • Export markets, especially in the U.S., may improve once tariff uncertainties clear.
  • Company is optimistic about enhancing market share and profitability through new product launches and expanded distribution.
  • Ongoing R&D and manufacturing initiatives (e.g., polyacrylamide solid) expected to positively impact growth.
  • The outlook remains positive both for the Indian chemical industry and the company’s long-term performance.
  • Sales growth driven by both domestic demand recovery and export expansion opportunities.

See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

  • Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
  • CAPEX for PAM solid estimated between ₹60 to ₹100 crores.
  • Additional upcoming projects include an amine manufacturing facility, with a feasibility study underway in collaboration with Koei Chemicals (Japan).
  • Total CAPEX for amine and other projects estimated around ₹50 crores.
  • Land registration for new parcels is near completion to create a land bank for future projects.
  • EC approval for the mines project at Jhagadia site is expected soon.
  • The pilot plant for PAM solid is near completion, with commercial plant expected to be ready by the fiscal year-end or next year’s first quarter.
  • Funding options for CAPEX include internal accruals, debt, or fresh equity; final decisions pending based on situation.

See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The transcript provided on page 15 does not explicitly mention the current or expected order book or pending orders for Black Rose Industries Limited. However, relevant points indicating positive business outlook and growth are: - The standalone business has exceeded FY22 figures in total volume. - The company is focusing on maximizing market share, outreach, sales, and profitability. - Outlook remains positive for the Indian chemical industry and the company. - New manufacturing products and R&D initiatives are expected to augment the product pipeline and improve year-on-year performance. - The company is proactively diversifying market outreach and adding new products. - Stable distribution business and steady local sales with new customer additions hint at a steady flow of orders. Specific quantitative details on order book or pending orders were not disclosed in the discussion available on page 15.

Key Metrics

How does Black Rose Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Black Rose Industries Ltd

See full Chemicals & Petrochemicals sector rankings

Price

108

Market Cap

₹588 Cr

P/E Ratio

20.5

Black Rose Industries Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹104 Cr, net profit ₹9 Cr.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Clean Science (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Yasho Industries (Q4 FY25)

    Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…

  • Vinati Organics (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

  • PCBL Chemical Ltd (Q4 FY25)

    Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Black Rose Industries Ltd Q4 FY25 results?

Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.

What is Black Rose Industries Ltd share price analysis?

Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 20.5 with a market cap of ₹588 Cr. Investors should review the full earnings analysis for detailed insights.

Is Black Rose Industries Ltd planning capital expenditure?

Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.

Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.